Mutations enhancing leucine-rich repeat kinase 2 (LRRK2) activity are a leading cause of familial Parkinson’s disease (PD), and genetic variation at the same locus significantly contributes to lifetime risk of idiopathic PD1–7. The gene discussed is LRRK2; the disease is Parkinson disease.